These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37208665)

  • 1. Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus.
    Shaaban Y; El-Marsafawy H; El-Farahaty RM; El-Ziny S; El-Refaey AM
    Pediatr Rheumatol Online J; 2023 May; 21(1):47. PubMed ID: 37208665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-4 IgG antibody-related disorders in patients with juvenile systemic lupus erythematosus.
    Moraitis E; Stathopoulos Y; Hong Y; Al-Obaidi M; Mankad K; Hacohen Y; Sen D; Hemingway C; Eleftheriou D
    Lupus; 2019 Sep; 28(10):1243-1249. PubMed ID: 31213132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus.
    Závada J; Nytrová P; Wandinger KP; Jarius S; Svobodová R; Probst C; Peterová V; Tegzová D; Pavelka K; Vencovský J
    Rheumatol Int; 2013 Jan; 33(1):259-63. PubMed ID: 22038193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study.
    Giani T; Smith EM; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Pregnolato F; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Cimaz R; Beresford MW; Hedrich CM;
    Lupus; 2021 Oct; 30(12):1955-1965. PubMed ID: 34601989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.
    Yang L; Li H; Xia W; Quan C; Zhou L; Geng D; Li Y
    Eur Radiol; 2020 Mar; 30(3):1470-1479. PubMed ID: 31748853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases.
    Katsumata Y; Kawachi I; Kawaguchi Y; Gono T; Ichida H; Hara M; Yamanaka H
    Mod Rheumatol; 2012 Sep; 22(5):676-84. PubMed ID: 22183613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
    Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and extensive spinal white matter involvement in neuromyelitis optica.
    Hayashida S; Masaki K; Yonekawa T; Suzuki SO; Hiwatashi A; Matsushita T; Watanabe M; Yamasaki R; Suenaga T; Iwaki T; Murai H; Kira JI
    Brain Pathol; 2017 May; 27(3):249-265. PubMed ID: 27082714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
    Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
    Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.
    Jarius S; Wildemann B
    Brain Pathol; 2013 Nov; 23(6):661-83. PubMed ID: 24118483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus.
    Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC
    Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory features, disease activity, and outcomes of juvenile systemic lupus erythematosus at diagnosis: a single-center study from southern China.
    Li W; Liu S; Zhong L; Chen C
    Clin Rheumatol; 2021 Nov; 40(11):4545-4552. PubMed ID: 34142297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
    Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
    Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
    Artim-Esen B; Şahin S; Çene E; Şahinkaya Y; Barut K; Adrovic A; Özlük Y; Kılıçaslan I; Omma A; Gül A; Öcal L; Kasapçopur Ö; İnanç M
    J Rheumatol; 2017 May; 44(5):619-625. PubMed ID: 28298568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.